$Relationship between gut microbiota and markers of myocardial fibrosis in with chronic heart failure with preserved ejection fraction$

Relationship between gut microbiota and markers of myocardial fibrosis in with chronic heart failure with preserved ejection fraction

Aim. To study the relationship of gut microbiota (GM) with serum myocardial fibrosis markers in patients with heart failure with preserved ejection fraction (HFpEF).Material and methods. The composition of the gut microbiota among 42 patients with HFpEF aged 67,0 [64,0; 71,5] years (men, 57,1%) was...

Full description

Bibliographic Details
Main Authors:	A. N. Kaburova, O. M. Drapkina, S. M. Yudin, S. N. Koretsky, V. V. Makarov, M. S. Pokrovskaya, S. A. Kraevoy, B. B. Shoybonov, I. A. Efimova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2021-07-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	gut microbiota heart failure with preserved ejection fraction diastolic dysfunction myocardial fibrosis
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2834

Similar Items

Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists
by: Ajmer Singh, et al.
Published: (2018-01-01)

Relationship between plasma aldosterone and left ventricular structure and function in patients with heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2021-03-01)

Cell Therapy for Heart Failure With Preserved Ejection Fraction∗
by: Barry A. Borlaug, MD, et al.
Published: (2016-01-01)

Cardiosphere-Derived Cells Reverse Heart Failure With Preserved Ejection Fraction in Rats by Decreasing Fibrosis and Inflammation
by: Romain Gallet, MD, et al.
Published: (2016-01-01)

Modern echocardiographic criteria for heart failure with preserved ejection fraction: not only diastolic dysfunction
by: O. M. Drapkina, et al.
Published: (2020-04-01)

The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle
by: V V Kirillova, et al.
Published: (2018-09-01)

Targeting heart failure with preserved ejection fraction: current status and future prospects
by: Kanwar M, et al.
Published: (2016-04-01)

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
by: Domenico D’Amario, et al.
Published: (2019-11-01)

Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score
by: Olivier Huttin, et al.
Published: (2021-06-01)

Clinical perspectives and evidence of diastolic stress test in heart failure with preserved ejection fraction
by: Evgeny Belyavskiy, et al.
Published: (2015-12-01)

Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study
by: Evgeny Belyavskiy, et al.
Published: (2020-09-01)

Novel algorithms for diagnosing heart failure with preserved ejection fraction in patients with hypertension and obesity
by: Yu. A. Vasyuk, et al.
Published: (2021-02-01)

Combination of Plasma Biomarkers and Clinical Data for the Detection of Myocardial Fibrosis or Aggravation of Heart Failure Symptoms in Heart Failure with Preserved Ejection Fraction Patients
by: Cho-Kai Wu, et al.
Published: (2018-11-01)

Effects of empagliflozin on exercise tolerance and left ventricular diastolic function in patients with heart failure with preserved ejection fraction and type 2 diabetes: a prospective single-center study
by: A. G. Ovchinnikov, et al.
Published: (2021-02-01)

Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
by: Dzhioeva O, et al.
Published: (2020-08-01)

Pentoxyphylline: possibilities to reduce manifestations of chronic heart failure with preserved left ventricular ejection fraction in elderly
by: V. B. Shatylo, et al.
Published: (2021-02-01)

ARTERIAL STIFFNESS IN CHRONIC HEART FAILURE
by: O. M. Drapkina, et al.
Published: (2014-07-01)

ARTERIAL STIFFNESS IN CHRONIC HEART FAILURE
by: O. M. Drapkina, et al.
Published: (2014-07-01)

TREATMENT OF CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH HYPERTENSION DISEASE: POTENTIAL THERAPEUTIC ROLE OF STATINES
by: S. G. Kanorsky, et al.
Published: (2018-01-01)

Utility and limitations of ejection fraction and of diastolic dysfunction in heart failure patients
by: Gian Francesco Mureddu, et al.
Published: (2019-04-01)

Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction—a systematic review and meta-analysis
by: Sharon Remmelzwaal, et al.
Published: (2020-10-01)

Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology ‐ Heart Failure Association EURObservational Research Programme Heart Failure Long‐Term Registry
by: Agnieszka Kapłon‐Cieślicka, et al.
Published: (2020-10-01)

Left atrial minimal volume: association with diastolic dysfunction and heart failure in patients in sinus rhythm or atrial fibrillation with preserved ejection fraction
by: Assaf Ben-Arzi, et al.
Published: (2021-05-01)

The Potential Therapeutic Role of Celastrol in Patients With Heart Failure With Preserved Ejection Fraction
by: Maryam Ajmal, et al.
Published: (2021-08-01)

High Neutrophil to Lymphocyte Ratio and Its Gene Signatures Correlate With Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction
by: Bo Bai, et al.
Published: (2021-06-01)

Evaluation of Patients with Heart Failure, Preserved Systolic Function and Diastolic Dysfunction
by: Florin Petru ANTON
Published: (2012-06-01)

Hubungan Kadar Apelin dengan Disfungsi Diastol pada Penderita Gagal Jantung dengan Fraksi Ejeksi Normal
by: Dini Rostiati, et al.
Published: (2015-06-01)

The Prognostic Value of the Left Ventricular End Diastolic Volume, Ejection Fraction and the Development of Dyarrhythmia in Ischemic Heart Disease.
by: Basil N. Saeed
Published: (2010-01-01)

Differential diagnosis and clinical management of diastolic heart failure: current best practice
by: Tawil J, et al.
Published: (2016-09-01)

Calcium channels blocker felodipin: perspectives in the treatment of arterial hypertension and chronic cardiac failure with normal ejection fraction
by: Oksana Mikhaylovna Drapkina, et al.
Published: (2011-12-01)

Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT
by: Anthony E. Peters, et al.
Published: (2021-04-01)

Profile of Hospitalized Hypertensives with Preserved and Reduced Left Ventricular Ejection Fraction in Nigeria
by: Akinsanya Daniel Olusegun-Joseph, et al.
Published: (2018-01-01)

Heart failure with preserved ejection fraction – onset
by: Branimir Kanazirev
Published: (2021-07-01)

Mitral early-diastolic inflow peak velocity (E)-to-left atrial strain ratio as a novel index for predicting elevated left ventricular filling pressures in patients with preserved left ventricular ejection fraction
by: You Zhou, et al.
Published: (2021-04-01)

Osteopontin – a biomarker of disease, but also of stage stratification of the functional myocardial contractile deficit by chronic ischaemic heart disease
by: Bogdan-Ioan Coculescu, et al.
Published: (2019-01-01)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Extracellular Matrix Remodeling during Left Ventricular Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
by: Merle M. Krebber, et al.
Published: (2020-09-01)

Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction
by: Anna Bobenko, et al.
Published: (2020-06-01)

Diagnosis of diastolic dysfunction in the emergency department: really at reach for minimally trained sonologists? A call for a wise approach to heart failure with preserved ejection fraction diagnosis in the ER
by: Gabriele Via, et al.
Published: (2018-10-01)

Left atrial conduit flow rate at baseline and during exercise: an index of impaired relaxation in HFpEF patients
by: Paolo N. Marino, et al.
Published: (2021-10-01)

Molecular biomarker profile of heart failure with mid-range and preserved ejection fraction in patients with type 2 diabetes
by: D. A. Lebedev, et al.
Published: (2020-11-01)